Livforsakringsbolaget Skandia’s Boston Scientific BSX Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$419K	Sell	9,827 -1,700	-15%	-$92.3K	0.01%	238
2026 Q1	$723K	Hold	11,527	–	–	0.03%	181
2025 Q4	$1.1M	Hold	11,527	–	–	0.04%	166
2025 Q3	$1.13M	Sell	11,527 -800	-6%	-$82.8K	0.04%	179
2025 Q2	$1.32M	Hold	12,327	–	–	0.06%	170
2025 Q1	$1.24M	Hold	12,327	–	–	0.07%	173
2024 Q4	$1.1M	Sell	12,327 -31,000	-72%	-$2.73M	0.06%	186
2024 Q3	$3.63M	Buy	43,327 +4,104	+10%	+$324K	0.2%	102
2024 Q2	$3.02M	Sell	39,223 -28,600	-42%	-$2.09M	0.25%	84
2024 Q1	$4.64M	Hold	67,823	–	–	0.39%	66
2023 Q4	$3.92M	Buy	67,823 +1,876	+3%	+$100K	0.37%	67
2023 Q3	$3.48M	Sell	65,947 -3,000	-4%	-$157K	0.38%	73
2023 Q2	$3.73M	Sell	68,947 -6,900	-9%	-$360K	0.39%	72
2023 Q1	$3.79M	Hold	75,847	–	–	0.4%	66
2022 Q4	$3.51M	Hold	75,847	–	–	0.4%	67
2022 Q3	$2.94M	Sell	75,847 -23,300	-24%	-$935K	0.36%	78
2022 Q2	$3.69M	Sell	99,147 -6,200	-6%	-$252K	0.32%	76
2022 Q1	$4.67M	Buy	105,347 +3,100	+3%	+$134K	0.31%	78
2021 Q4	$4.34M	Buy	102,247 +40,700	+66%	+$1.71M	0.28%	87
2021 Q3	$2.67M	Buy	61,547 +30,800	+100%	+$1.36M	0.17%	129
2021 Q2	$1.31M	Buy	30,747 +9,300	+43%	+$391K	0.08%	211
2021 Q1	$829K	Hold	21,447	–	–	0.06%	243
2020 Q4	$771K	Buy	21,447 +6,700	+45%	+$241K	0.07%	239
2020 Q3	$563K	Hold	14,747	–	–	0.06%	231
2020 Q2	$518K	Hold	14,747	–	–	0.06%	238
2020 Q1	$481K	Buy	14,747 +4,300	+41%	+$168K	0.07%	213
2019 Q4	$472K	Sell	10,447 -5,200	-33%	-$218K	0.06%	231
2019 Q3	$637K	Hold	15,647	–	–	0.08%	214
2019 Q2	$673K	Buy	15,647 +2,000	+15%	+$76.9K	0.08%	197
2019 Q1	$524K	Buy	13,647 +1,400	+11%	+$53.5K	0.07%	219
2018 Q4	$433K	Hold	12,247	–	–	0.06%	230
2018 Q3	$472K	Sell	12,247 -12,300	-50%	-$430K	0.06%	261
2018 Q2	$803K	Buy	24,547 +3,700	+18%	+$112K	0.07%	234
2018 Q1	$570K	Hold	20,847	–	–	0.06%	293
2017 Q4	$517K	Sell	20,847 -5,100	-20%	-$141K	0.05%	314
2017 Q3	$757K	Hold	25,947	–	–	0.07%	270
2017 Q2	$719K	Hold	25,947	–	–	0.07%	274
2017 Q1	$645K	Sell	25,947 -66,800	-72%	-$1.62M	0.06%	284
2016 Q4	$2.01M	Buy	92,747 +84,647	+1,045%	+$1.85M	0.1%	214
2016 Q3	$285K	Sell	8,100 -118,547	-94%	-$2.83M	0.01%	661
2016 Q2	$2.96M	Hold	126,647	–	–	0.13%	180
2016 Q1	$2.38M	Hold	126,647	–	–	0.11%	206
2015 Q4	$2.33M	Sell	126,647 -14,800	-10%	-$265K	0.11%	199
2015 Q3	$2.32M	Hold	141,447	–	–	0.12%	190
2015 Q2	$2.5M	Hold	141,447	–	–	0.12%	182
2015 Q1	$2.51M	Buy	141,447 +33,300	+31%	+$526K	0.12%	191
2014 Q4	$1.43M	Sell	108,147 -84,900	-44%	-$1.09M	0.07%	372
2014 Q3	$2.28M	Hold	193,047	–	–	0.09%	274
2014 Q2	$2.46M	Hold	193,047	–	–	0.09%	253
2014 Q1	$2.61M	Buy	+193,047	New	+$2.53M	0.1%	223

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Livforsakringsbolaget Skandia's BSX Position: Q2 2026 in Review

Livforsakringsbolaget Skandia reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $92.3K and leaving 9,827 shares worth $419K. The position accounts for 0.01% of the portfolio, ranked #238.

Livforsakringsbolaget Skandia first reported a position in BSX in Q1 2014 and has held it in 50 quarters since. The position peaked at $4.67M in Q1 2022. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Livforsakringsbolaget Skandia held 9,827 shares of Boston Scientific worth $419K as of Q2 2026.
Livforsakringsbolaget Skandia sold 1,700 Boston Scientific shares in Q2 2026, an estimated $92.3K.
Boston Scientific made up 0.01% of Livforsakringsbolaget Skandia's portfolio in Q2 2026, its #238 holding.
Livforsakringsbolaget Skandia first reported a position in Boston Scientific in Q1 2014 and has held it in 50 quarters since.
Livforsakringsbolaget Skandia's Boston Scientific position peaked at $4.67M in Q1 2022.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q2 2026, filed 18 Aug 2026.